Table 5.
Species | Extract or Sample | Test Microorganism | Antimicrobial Activity—MIC, MBC, IZ, etc. | Test Methods | Reference |
---|---|---|---|---|---|
Dunaliella sp. | EtOAc and MeOH extracts from a hexane extract | Biofilm-forming strains causing clinical infections: S. aureus, CNS, S. epidermidis, E. coli, K. pneumonia, E. cloacae and P. aeruginosa; fungi (C. albicans and C. parapsilosis resistant to fluconasole) | No antibacterial and biofilm-inhibiting effect activity on the test strains, which included strains with different resistance profiles towards clinical treatments, such as S. aureus, E. coli and C. parapsilosis | BMD, biofilm formation assay | [174] |
Dunaliella sp. from Moroccan coastlines | EtOH extract | E. coli, S. aureus and P. aeruginosa; fungi—C. albicans and A. niger | Moderately inhibited E. coli, S. aureus and C. albicans with MIC > 5 mg/mL, and P. aeruginosa with MIC 4.3 mg/mL but not A. niger at 5 mg/mL | BMD | [61] |
Dunaliela sp. from the Aegean Sea | EtOH extracts | Ten pathogens—E. faecalis, S. aureus and MRSA; E. coli, K. pneumoniae, S. flexneri and V. cholera; fungi—A. fumigatus, C. albicans and C. neoformans; the fouling bacteria A. hydrophila, A. salmonicida, A. borkumensis, Alcanivorax sp., Allivibrio salmonicida, E. litoralis, P. donghaensis, Pseudoalteromonas sp., P. mendocina and V. furnissii | No effect | AWDM (1 mg/disc), BMD | [177] |
D. tertiolecta | Aqueous, sodium acetate and CHCl3-MeOH extracts | Staphylococcus spp. isolates causing goat (19 strains) and bovine (16 strains) mastitis | MIC50 = 3–25 μg/mL, MICs = 25 μg/mL (aqueous extract), >100 μg/mL (the rest against bovine mastitis strains) MICs = 50, 100 and >100 μg/mL μg/mL (goat mastitis strains) |
BMD | [151] |
D. tertiolecta | MeOH extract | 114 bacterial and 11 fungal strains from ear swabs from patients with external otitis using for over one year: Staphylococcus spp. (28.8%) and P. aeruginosa (24.8%). Many of the strains, except Klebsiella spp., could form biofilms. Only three S. aureus strains and 11 CNS showed resistance to methicillin | MIC50 and the MIC ranges against S. aureus = 5.6 × 109 and 2.8 × 109–1.1 × 1010 algae cells/mL, P. aeruginosa = 2.8 × 109 and 1.4 × 109–5.6 × 109 algae cells/mL, Enterobacteriaceae (strains of E. coli and Klebsiella spp.,) = 2.2 × 1010 and 1.1 × 1010–2.2 × 1010 algae cells/mL |
BMD (MIC measured as algae cells/mL) | [178] |
D. tertiolecta | Hexane extract and DCM and MeOH fractions from it | E. coli, P. aeruginosa, Klebsiella pneumoniae, B. subtilis, S. aureus and M. luteus | Active only against B. subtilis and S. aureus with IZs ranging from 8.9 to 11.6 mm | Agar diffusion method (the Oxford cup method) | [181] |
D. parva | dH2O extracts made with freezing and thawing | Four test strains of opportunistic bacteria (E. coli, K. ozaenae, P. aeruginosa and S. aureus) | <20% growth inhibition; peloid-containing extracts of cells had a pronounced antibacterial effect against opportunistic bacteria | BMD, photometric method | [56] |
Dunaliella sp. | Total carotenoid extract |
E. coli, Salmonella sp., P. aeruginosa, B. cereus, Klebsiella sp.; Mice inoculated with H. pylori |
E. coli and Salmonella sp.: no activity up to 100 mg/mL; P. aeruginosa: probiotic activity at 100 mg/mL only; B. cereus: inhibition at 6.25 mg/mL; Klebsiella sp.: inhibition at 25 mg/mL. From three microalgal species, only Dunaliella sp. healed the stomach in 14 days, highest ability to promote gastric healing due to antioxidant and antimicrobial effect | DDM, in vivo gastritis studies on model mice | [173] |
D. tertiolecta | Aqueous and acidified MeOH extract | V. campbellii, Vibrio-challenged L. vannamei shrimp cultures | 12–13% growth inhibition (the aqueous extract at 78–313 μg/mL. Exact MIC not determined due to variation in the inhibition at different concentrations. No clear anti-Vibrio activity for the MeOH extract and in the in vivo test when the alga was used as green-water cultures | BMD, in vivo shrimp challenge assay | [84] |
D. tertiolecta | Biomass as a feed | Artemia (brine shrimp) challenged with Vibrio | Full protection against vibriosis in terms of survival and viable parameters. This effect could be due to the immune-stimulating effect or antibacterial compounds | In vivo challenge test after daily feeding | [122] |